Your initiative, our cause
Private Access

Collaboration Agreement with the Girona Institute of Biomedical Research Dr. Josep Trueta (IdibGi)

The Girona Institute of Biomedical Research (IDIGBI) is a research centre that belongs to the CERCA network of centres of the Government of Catalonia, and whose purpose is to promote, develop, manage, transfer and disseminate biomedical research, scientific and technological knowledge, teaching and training in the field of life and health sciences, mainly around Girona

The IDIBGI is structured with research groups and research staff from the field of health and biomedical research of the University Hospital Dr. Josep Trueta of Girona (HUJT) and the University of Girona (UdG), the Institute of Diagnostic Imaging (IDI), the Catalan Institute of Oncology (ICO) and the Institute of Primary Care (IAP) / Catalan Institute of Health (ICS) in Girona. The IDIBGI facilities at the Parc Hospitalari Martí i Julià in Salt are home to part of the laboratories and research staff who, together with the other researchers from the associated institutions, form multidisciplinary teams with different expertise focused on finding synergies and solutions to the health challenges of our surroundings, through translational research.

The Bosch Aymerich Foundation, with its commitment to scientific research, has signed a collaboration agreement with IDIGBI. This agreement will fund a predoctoral grant in the research project: development of new tumour therapies, led by Dr. Jordi Frigola Mas. The main goal of this study is to improve one of the main limitations of current treatments: their high toxicity. The development of new molecular tools, which allow cell proliferation to be stopped without inducing genomic damage, together with greater specificity for tumour cells, will reduce the toxicity of current tumour treatments and significantly improve the cancer patients’ quality of life.

The signing took place on 17 January in the presence of Mr. Angel Dutras, trustee of the Bosch Aymerich Foundation, Ms. Anna Ribas, directress of the institute and Dr. Jordi Frigola Mas, the Head Researcher of the Chromosomal Replication Group in which the research project will be developed.